Mariam de la Poza Abad, MD; Gemma Mas Dalmau, MD; Mikel Moreno Bakedano, MD, PhD; et al.
free access
JAMA Intern Med. 2016;176(1):21-29. doi:10.1001/jamainternmed.2015.7088
This trial of patients with uncomplicated respiratory infections randomizes participants to 1 of 4 antibiotic prescription strategies to determine whether delayed antibiotic strategies are associated with greater symptom burden and duration, as well as reduced antibiotic use.
-
Invited Commentary
Delayed Antibiotic Prescribing Strategies鈥擳ime to Implement?
Amanda R. McCullough, PhD; Paul P. Glasziou, PhD
JAMA Intern Med
Less Is More
Stacey L. Sheridan, MD, MPH; Anne Sutkowi-Hemstreet, MPH; Colleen Barclay, MPH; et al.
free access
JAMA Intern Med. 2016;176(1):31-41. doi:10.1001/jamainternmed.2015.7339
This clinical trial examines the effect of 3 different presentations of benefits and harms on patients鈥� intentions to accept low-value or potentially low-value screening services.
Martina R. Bally, MD; Prisca Z. Blaser Yildirim, MD; Lisa Bounoure, PhD; et al.
free access
JAMA Intern Med. 2016;176(1):43-53. doi:10.1001/jamainternmed.2015.6587
This systematic review and meta-analysis of randomized clinical trials assesses the effects of nutritional support on outcomes of medical inpatients with malnutrition or at risk for malnutrition.
-
Invited Commentary
Nutritional Support on the Medical Wards鈥擳hought for Food
Jonathan P. Kushner, MD; Joseph A. Lacy, RD; Steven R Gay, MD
JAMA Intern Med
Health Care Reform
Tewodros Eguale, MD, PhD; David L. Buckeridge, MD, PhD; Aman Verma, PhD; et al.
free access
JAMA Intern Med. 2016;176(1):55-63. doi:10.1001/jamainternmed.2015.6058
This cohort study of off-label use of prescription drugs assesses the risks for and prevalence of adverse drug events documented in the electronic health records of adults seeking medical treatment under a national health insurance system.
Harinder S. Chahal, PharmD, MSc; Elliot A. Marseille, PhD; Jeffrey A. Tice, MD; et al.
free access
JAMA Intern Med. 2016;176(1):65-73. doi:10.1001/jamainternmed.2015.6011
This decision-analytic model of treatment for hepatitis C virus genotype 1 assesses the cost-effectiveness of treating all patients with hepatitis C virus infection at all stages of fibrosis vs those with advanced fibrosis only in a US treatment-naive population sample.
-
Invited Commentary
Treatment of Hepatitis C Virus Infection in Real Life
Hal F. Yee Jr, MD, PhD
JAMA Intern Med
Albert Y. Liu, MD, MPH; Stephanie E. Cohen, MD, MPH; Eric Vittinghoff, PhD; et al.
free access
JAMA Intern Med. 2016;176(1):75-84. doi:10.1001/jamainternmed.2015.4683
This study tested the efficacy of preexposure prophylaxis for HIV and other sexually transmitted infections in a population of men who have sex with men and transgender women.
-
Invited Commentary
Optimizing Delivery of Preexposure Prophylaxis鈥擳he Next Frontier
Raphael J. Landovitz, MD, MSc
JAMA Intern Med
Ravi V. Shah, MD; Venkatesh L. Murthy, MD, PhD; Laura A. Colangelo, MS; et al.
free access
JAMA Intern Med. 2016;176(1):87-95. doi:10.1001/jamainternmed.2015.6309
This review examines whether cardiorespiratory fitness in US young adults is associated with clinical outcomes and subclinical cardiovascular disease at a 25-year follow-up reassessment.
Allan J. Walkey, MD, MSc; Janice Weinberg, ScD; Renda Soylemez Wiener, MD, MPH; et al.
free access
JAMA Intern Med. 2016;176(1):97-104. doi:10.1001/jamainternmed.2015.6324
This cohort study evaluates the results of a lack of data on patients鈥� do-not-resuscitate status as part of mortality outcomes in assessment of a hospital鈥檚 quality.